MYASTHENIA GRAVIS, MUSK

Clinical trials for MYASTHENIA GRAVIS, MUSK explained in plain language.

Never miss a new study

Get alerted when new MYASTHENIA GRAVIS, MUSK trials appear

Sign up with your email to follow new studies for MYASTHENIA GRAVIS, MUSK, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New drug trial aims to ease debilitating muscle weakness

Disease control Recruiting now

This study is testing whether a new medication called NMD670 can help reduce symptoms of myasthenia gravis, a condition that causes muscle weakness. About 84 adults with moderate to severe myasthenia gravis will take either the medication or a placebo pill twice daily for 21 days…

Matched conditions: MYASTHENIA GRAVIS, MUSK

Phase: PHASE2 • Sponsor: NMD Pharma A/S • Aim: Disease control

Last updated Apr 02, 2026 14:56 UTC

MYASTHENIA GRAVIS, MUSK

Get alerted when new MYASTHENIA GRAVIS, MUSK trials appear

New drug trial aims to ease debilitating muscle weakness